AUG 01, 2017 6:00 PM KST

사례연구: 세포 치료제 제조 확장하기

Sponsored by: TERUMO BCT
Speaker
  • Sr. Manager, Global Strategic Medical Affairs, Cell Therapy Technologies - Terumo BCT
    Biography
      Jim recently transitioned to the Global Strategic Medical Affairs team to better leverage both his technical background and the commercial exposure he has gained during his more than seven years at Terumo BCT. Prior to joining the cell processing team at Terumo BCT, Dr. Beltzer was the lead scientist for the research and development of Synthemax™, a synthetic growth surface for the culture of human embryonic stem cells, at Corning Life Sciences. He was a co-founder of RETT Corporation and was a key player in the industrialization of several technology platforms, including phage display and yeast two-hybrid. He has more than 25 years of industrial research and development experience in a broad range of disciplines.

    Abstract

    DATE: August 2, 2017
    TIME: 10:00AM HKT

    OR

    DATE: August 1, 2017
    TIME: 6:00PM PT, 7:00PM MT

     

    폐쇄된 자동 세포 배양 프로세스의 사용을 통한 T-세포 확장, 바이러스 벡터 생산 및 중간엽줄기세포(MSC)의 확장 생산에 대한 식견 갖기.

    Dr. Beltzer (Terumo BCT, CO, U.S.)는 프로세스 개발 및 경제적 목표가 업계 및 학계에서 어떻게 달성되었는지를 설명하기 위해 여러 사례연구를 제시할 것입니다. 그 결과에는 12일 내 T 세포의 최고 500배 증가, 동종이계 세포 치료에 대한 상품 비용(COG) 40% 감소 및 플라스크 기반 프로세스와 유사한 역가를 갖춘 자동화된 바이러스 벡터 생산 등을 포함합니다. 이러한 목표들을 달성하기 위해 종종 필요한 프로세스 변경에 특히 초점이 맞추어질 것입니다.

    누가 관심을 가져야 하는가?
    • 임상 실험자, 연구자, 실험실 기술자 및 세포치료업계 전문가
    • 세포 치료제 제조 전문가
    • 유전자 및 면역치료제 제조 전문가
     

    Learning Objectives:

    • 중공사막 생물반응기(hollow-fiber bioreactor) 시스템을 사용한 T 세포 확장의 새로운 결과
    • 중간엽줄기세포(MSC)의 생산 확장을 위한 기법
    • 바이러스 벡터 생산에 대한 새로운 접근법
    • 비용 및 인건비 절감 달성에 대한 사례연구

     


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources
    Attendees
    • See more